CSL reported $6.47B in Stock for its fiscal semester ending in June of 2025.





Stock Change Date
aTyr Pharma USD 2.79M 67.83K Mar/2026
Cara Therapeutics USD 900K 0 Mar/2025
CSL USD 6.47B 327M Jun/2025
TherapeuticsMD USD 6.7M 551K Sep/2022